Bg pattern

RABEPRAZOL SANDOZ 20 mg GASTRO-RESISTANT TABLETS

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use RABEPRAZOL SANDOZ 20 mg GASTRO-RESISTANT TABLETS

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Package Leaflet: Information for the User

Rabeprazol Sandoz 20 mg Gastro-Resistant Tablets EFG

rabeprazol sodium

Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.

  • Keep this leaflet, you may need to read it again.
  • If you have any further questions, ask your doctor or pharmacist.
  • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
  • If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.

Contents of the pack and other information

  1. What is Rabeprazol Sandoz and what is it used for
  2. What you need to know before you take Rabeprazol Sandoz
  3. How to take Rabeprazol Sandoz
  4. Possible side effects
  5. Storage of Rabeprazol Sandoz
  6. Contents of the pack and other information

1. What is Rabeprazol Sandoz and what is it used for

Rabeprazol Sandoz belongs to a group of medicines called “Proton Pump Inhibitors”. These medicines reduce the amount of acid produced by the stomach.

Rabeprazol Sandoz is used in adults to treat the following conditions:

  • ulcers in the intestine (also called duodenal ulcer),
  • ulcers in the stomach (also called benign gastric ulcer),
  • to relieve symptoms of heartburn caused by gastro-oesophageal reflux disease (GORD), which is also known as reflux oesophagitis,
  • long-term treatment of GORD to prevent the return of symptoms,
  • to relieve symptoms of moderate to very severe GORD (symptomatic GORD) such as heartburn and acid regurgitation,
  • severe increase of acid production in the stomach (Zollinger-Ellison syndrome),
  • treatment of infections caused by a bacterium called Helicobacter pylori (H. pylori) when given in combination with antibiotic treatment.
Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before you take Rabeprazol Sandoz

Do not take Rabeprazol Sandoz

  • if you are allergic to rabeprazol or any of the other ingredients of this medicine (listed in section 6),
  • if you are pregnant or think you may be pregnant,
  • if you are breast-feeding.

Do not take Rabeprazol Sandoz if you are in any of the above situations. If you are not sure, consult your doctor or pharmacist before taking Rabeprazol Sandoz.

Warnings and precautions

Consult your doctor or pharmacist before starting treatment with rabeprazol:

  • if you are allergic to proton pump inhibitors or “substituted benzimidazoles”,
  • if you have a stomach tumour,
  • if you have been treated with rabeprazol for a long period of time (more than one year), you will need to have regular check-ups with your doctor,
  • if you have or have had liver problems, you must inform your doctor. Your doctor may need to check your liver function more frequently,
  • if you are taking atazanavir (a medicine used to treat HIV), it is not recommended to take rabeprazol (see section 2),
  • if you have reduced body stores or have risk factors for reduced vitamin B12 and are taking long-term treatment with rabeprazol sodium. As with all acid-reducing agents, rabeprazol sodium may lead to a reduced absorption of vitamin B12,
  • if you are due to have a specific blood test (Chromogranin A),
  • if you have ever had a skin reaction with a medicine used to reduce stomach acid,

similar to rabeprazol.

  • during treatment with rabeprazol, kidney inflammation may occur. Signs and symptoms include: decreased urine output or blood in the urine and/or hypersensitivity reactions such as fever, rash and joint stiffness. You should inform your doctor of these signs.

If you experience severe diarrhoea with symptoms such as fever, abdominal pain or tenderness, stop taking rabeprazol and consult your doctor immediately.

If you take a proton pump inhibitor like rabeprazol, especially over a period of more than one year, you may have a slightly increased risk of fractures of the hip, wrist or spine. Inform your doctor if you have osteoporosis or if you are taking corticosteroids (which can increase the risk of osteoporosis).

Children

Rabeprazol should not be given to children.

Using Rabeprazol Sandoz with other medicines

Tell your doctor or pharmacist if you are using, have recently used or might use any other medicines.

Tell your doctor before taking this medicine if you are taking:

  • ketoconazole or itraconazole (medicines for fungal infections), the dose may need to be adjusted,
  • atazanavir (a medicine used to treat HIV), rabeprazol may decrease the blood levels of this medicine, so they should not be used at the same time,
    • methotrexate (a chemotherapy medicine used at high doses to treat cancer), if you are being treated with methotrexate at high doses, your doctor may temporarily stop your treatment with rabeprazol.

If you are in doubt, consult your doctor or pharmacist before taking rabeprazol.

Pregnancy and breast-feeding

If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.

Do not take Rabeprazol Sandoz if you are pregnant or breast-feeding.

Driving and using machines

Rabeprazol normally does not affect your ability to drive or use machines. However, this medicine may cause drowsiness in some patients. If you are affected, do not drive or operate machines.

Rabeprazol Sandoz contains sodium

This medicine contains less than 23 mg of sodium (1mmol) per tablet; this is essentially “sodium-free”.

3. How to take Rabeprazol Sandoz

Take this medicine exactly as your doctor has told you. If you are not sure, check with your doctor or pharmacist.

If you are taking rabeprazol once a day, the tablets should be taken preferably before breakfast.

Swallow the tablet whole. Do not chew or crush the tablet.

Duodenal ulcers

The usual dose is 20 mg once a day for 4 weeks. Your doctor will decide if you need to continue treatment for another 4 weeks.

Gastric ulcers

The usual dose is 20 mg once a day for 6 weeks. Your doctor will decide if you need to continue treatment for another 6 weeks.

Gastro-oesophageal reflux disease (GORD)

The usual dose is 20 mg once a day for 4-8 weeks.

Long-term treatment of GORD

The usual maintenance dose is 10 mg or 20 mg once a day. If you are on long-term treatment, you should see your doctor regularly to review your treatment and symptoms.

Treatment of symptoms of moderate to very severe GORD

The usual dose is 10 mg once a day for 4 weeks.

If symptoms do not disappear after 4 weeks, consult your doctor. After the first 4-week treatment, if symptoms return, your doctor may tell you to take a 10 mg tablet when needed to control your symptoms.

Zollinger-Ellison syndrome

The usual starting dose is 60 mg once a day. The dose may be adjusted by your doctor depending on how you respond to treatment. You may be given up to 60 mg twice a day. Your doctor will tell you how many tablets to take, when to take them and for how long you need to take them.

Treatment of infections caused by H. pyloriwhen given in combination with antibiotic treatment

The usual dose is 20 mg twice a day in combination with two antibiotics. The recommended combination is:

Rabeprazol 20 mg + clarithromycin 500 mg + amoxicillin 1 g, taken together twice a day for 7 days.

Patients with liver and kidney problems

No dose adjustment is necessary.

Use in children

Do not give these tablets to children.

If you take more Rabeprazol Sandoz than you should

If you have taken more rabeprazol than you should, consult your doctor, pharmacist or call the national Poison Information Centre (telephone 91 562 04 20), stating the medicine and the amount taken.

Take this leaflet and the medicine or the box with you to the doctor or hospital, so they know how many tablets you have taken.

If you forget to take Rabeprazol Sandoz

It is important that you take your medicine every day, as this will help your treatment to be more effective. However, if you forget to take one or more doses, take another as soon as you remember and then continue as your doctor has told you. Do not take a double dose to make up for forgotten doses.

If you have any further questions on the use of this product, ask your doctor or pharmacist.

If you stop taking Rabeprazol Sandoz

Normally, relief of symptoms occurs before the ulcer is completely healed. It is important that you do not stop treatment until your doctor tells you to.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

Serious side effects

You should contact your doctor immediatelyif you notice any of the following serious side effects(can be any allergic reaction).

Rare side effects (may affect up to 1 in 1,000 patients)

  • swelling of the face, lips, tongue and throat which may cause difficulty in breathing, speaking or swallowing, sudden drop in blood pressure, paleness, feeling of fainting or collapse.

Very rare side effects (may affect up to 1 in 10,000 patients)

  • blisters on the skin and/or mucous membranes of the lips, eyes, mouth, nasal passages or genitals (Stevens-Johnson syndrome) or skin peeling (toxic epidermal necrolysis).

Other possible side effects

Common side effects(may affect more than 1 in 10 patients)

  • headache, dizziness,
  • insomnia,
  • cough, sore throat, runny nose and nasal congestion,
  • diarrhoea, vomiting, nausea, stomach pain, constipation, gas (flatulence),
  • general pain, back pain,
  • infection,
  • weakness, flu-like symptoms,
  • benign polyps in the stomach.

Uncommon side effects(may affect up to 1 in 100 patients)

  • nervousness, drowsiness,
  • cough with phlegm, chest pain and fever,
  • feeling of pressure or pain in the cheeks and forehead,
  • indigestion, dry mouth, belching,
  • rash, redness of the skin,
  • muscle pain, leg cramps, joint pain,
  • urinary tract infection,
  • chest pain, chills, fever,
  • increase in liver enzymes,
  • fracture of the hip, wrist and spine.

Rare side effects(may affect up to 1 in 1,000 patients)

  • blood disorders that may lead to frequent infections, easy bruising or bleeding, or anaemia,
  • loss of appetite (anorexia),
  • vision disorders,
  • gastritis, which may cause stomach pain and nausea,
  • mouth pain,
  • taste disturbances,
  • liver disease (hepatitis), which may cause yellowing of the skin or the whites of the eyes (jaundice),
  • liver failure that can lead to brain damage in patients who have previously had liver disease,
  • itching and blistering skin, usually disappearing after treatment is stopped,
  • sweating,
  • kidney problems, which may cause high or low urine output,
  • weight increase,
  • depression,
  • hypersensitivity (including allergic reactions).

Side effects with unknown frequency(frequency cannot be estimated from the available data)

  • low levels of sodium in the blood,
  • low levels of magnesium in the blood*,
  • confusion,
  • breast enlargement in men,
  • swelling of the ankles, feet or fingers,
  • skin rash, possibly with pain in the joints,
  • inflammation of the intestine (leading to diarrhoea).

*If you are taking rabeprazol for more than three months, it is possible that the levels of magnesium in your blood may fall. Low levels of magnesium can cause fatigue, involuntary muscle contractions, disorientation, convulsions, dizziness and a rapid heart rate. If you get any of these symptoms, please tell your doctor immediately. Low levels of magnesium can also lead to a reduction in the levels of potassium and calcium in the blood. Your doctor may decide to perform regular blood tests to monitor your levels of magnesium.

Reporting of side effects

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Spanish Pharmacovigilance System for Medicinal Products for Human Use: https://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storage of Rabeprazol Sandoz

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the blister and carton after EXP. The expiry date refers to the last day of the month stated.

Do not store above 25°C. Store in the original package to protect from moisture.

Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.

6. Contents of the pack and other information

What is in Rabeprazol Sandoz

  • The active substance is rabeprazol sodium.

Each gastro-resistant tablet of 20 mg contains 20 mg of rabeprazol sodium.

  • The other ingredients are:

Core: calcium hydroxide, mannitol, low-substituted hydroxypropylcellulose and sodium stearyl fumarate.

Intermediate coating: hypromellose and talc.

Gastro-resistant coating: hypromellose phthalate, dibutyl sebacate, yellow iron oxide (E172) and titanium dioxide (E171).

Appearance and packaging

Rabeprazol Sandoz 20 mg are yellow, round and biconvex gastro-resistant tablets.

Al/Al blister pack with desiccant: 5, 7, 10, 14, 15, 20, 25, 28, 30, 37, 50, 56, 60, 75, 90, 98, 100 and 120 gastro-resistant tablets.

Not all pack sizes may be marketed.

Marketing authorisation holder and manufacturer

Marketing authorisation holder

Sandoz Farmacéutica, S.A.

Centro Empresarial Parque Norte

Edificio Roble

C/ Serrano Galvache, 56

28033 Madrid

Spain

Manufacturer

Lek Pharmaceuticals d.d.

Verovskova 57

1526 Ljubljana

Slovenia

or

Salutas Pharma GmbH

Otto-von-Guericke-Allee 1

39179 Barleben

Germany

or

Lek S.A.

ul. Domaniewska 50 C

02-672 Warszawa

Poland

or

Lek Pharmaceuticals d.d.

Trimlini 2D

9220 Lendava

Slovenia

This medicine is authorised in the Member States of the European Economic Area under the following names:

Austria:

Rabeprazol Sandoz 20 mg - magensaftresistente Tabletten

Czech Republic:

Rapoxol 20 mg

Spain:

Rabeprazol Sandoz 20 mg comprimidos gastrorresistentes EFG

France:

RABEPRAZOLE SANDOZ, 20 mg, comprimé gastro-résistant

Hungary:

Rabeprazol 1 A Pharma 20 mg gyomornedv-ellenálló tabletta

Netherlands:

Rabeprazolnatrium Sandoz 20 mg, maagsapresistente tabletten

Portugal:

Rabeprazol Sandoz

Slovenia:

Rabeprazol Lek 20 mg gastrorezistentne tablete

Date of last revision of this leaflet:

Detailed and up-to-date information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/

Online doctors for RABEPRAZOL SANDOZ 20 mg GASTRO-RESISTANT TABLETS

Discuss questions about RABEPRAZOL SANDOZ 20 mg GASTRO-RESISTANT TABLETS, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (37)
Doctor

Dmytro Horobets

Family medicine 7 years exp.

Dr. Dmytro Horobets is a licensed family medicine physician in Poland, specialising in endocrinology, diabetology, obesity management, gastroenterology, pediatrics, general surgery, and pain medicine. He offers online consultations for adults and children, providing personalised medical support for a wide range of acute and chronic health concerns.

Areas of expertise:

  • Endocrinology: diabetes type 1 and type 2, prediabetes, thyroid disorders, metabolic syndrome, hormonal imbalance.
  • Obesity medicine: structured weight management plans, nutritional counselling, obesity-related health risks.
  • Gastroenterology: acid reflux (GERD), gastritis, irritable bowel syndrome (IBS), liver and biliary conditions.
  • Pediatric care: infections, respiratory symptoms, digestive issues, growth and development monitoring.
  • General surgery support: pre- and post-surgical consultations, wound care, rehabilitation.
  • Pain management: chronic and acute pain, back pain, joint pain, post-traumatic pain syndromes.
  • Cardiovascular health: hypertension, cholesterol control, risk assessment for heart disease.
  • Preventive medicine: regular check-ups, health screenings, long-term management of chronic conditions.

Dr. Horobets combines evidence-based medicine with a patient-centred approach. He carefully evaluates each patient’s medical history and symptoms, offering clear explanations and structured treatment plans adapted to individual needs.

Whether you need help managing diabetes, tackling weight-related health issues, interpreting lab results, or receiving general family medicine support, Dr. Horobets provides professional online care tailored to your specific health goals.

Camera Book a video appointment
€60
5.0 (5)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques. For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance. Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults. In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions. Patients commonly seek his care for: 

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns

Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.

Camera Book a video appointment
€80
5.0 (181)
Doctor

Yevgen Yakovenko

General surgery 12 years exp.

Dr. Yevgen Yakovenko is a licensed surgeon and general practitioner in Spain and Germany. He specialises in general, paediatric, and oncological surgery, internal medicine, and pain management. He offers online consultations for adults and children, combining surgical precision with therapeutic support. Dr Yakovenko works with patients across different countries and provides care in Ukrainian, Russian, English, and Spanish.

Areas of medical expertise:

  • Acute and chronic pain: headaches, muscle and joint pain, back pain, abdominal pain, postoperative pain. Identifying the cause, selecting treatment, and creating a care plan.
  • Internal medicine: heart, lungs, gastrointestinal tract, urinary system. Management of chronic conditions, symptom control, second opinions.
  • Pre- and postoperative care: risk assessment, decision-making support, follow-up after surgery, rehabilitation strategies.
  • General and paediatric surgery: hernias, appendicitis, congenital conditions, both planned and urgent surgeries.
  • Injuries and trauma: bruises, fractures, sprains, soft tissue damage, wound care, dressing, referral when in-person care is required.
  • Oncological surgery: diagnosis review, treatment planning, and long-term follow-up.
  • Obesity treatment and weight management: a medical approach to weight loss, including assessment of underlying causes, evaluation of comorbidities, development of a personalised plan (nutrition, physical activity, pharmacotherapy if needed), and ongoing progress monitoring.
  • Imaging interpretation: analysis of ultrasound, CT, MRI, and X-ray results, surgical planning based on imaging data.
  • Second opinions and medical navigation: clarifying diagnoses, reviewing current treatment plans, helping patients choose the best course of action.

Experience and qualifications:

  • 12+ years of clinical experience in university hospitals in Germany and Spain.
  • International education: Ukraine – Germany – Spain.
  • Member of the German Society of Surgeons (BDC).
  • Certified in radiological diagnostics and robotic surgery.
  • Active participant in international medical conferences and research.

Dr Yakovenko explains complex topics in a clear, accessible way. He works collaboratively with patients to analyse health issues and make evidence-based decisions. His approach is grounded in clinical excellence, scientific accuracy, and respect for each individual.

If you are unsure about a diagnosis, preparing for surgery, or want to discuss your test results – Dr Yakovenko will help you evaluate your options and move forward with confidence.

Camera Book a video appointment
€50
0.0 (0)
Doctor

Joao Silva

General medicine 6 years exp.

Dr. João Silva is a physician with training and experience in the field of General and Family Medicine, dedicated to providing healthcare focused on the well-being and quality of life of his patients. Throughout his professional career, he has developed broad clinical competencies, striving to maintain a medical practice based on scientific evidence and continuous knowledge updates.

Between 2013 and 2019, he completed the Integrated Master's Degree in Medicine at the Abel Salazar Institute of Biomedical Sciences in Porto, where he acquired a solid academic and clinical education.

Subsequently, between January 2021 and December 2021, he completed the General Internship at the Entre Douro e Vouga Hospital Center in Santa Maria da Feira, where he had the opportunity to work in different hospital settings and deepen his competencies in several areas of medicine.

From January 2022 until March 2026, he works as a Resident Physician in General and Family Medicine at USF Salvador Machado in Oliveira de Azeméis, developing clinical activities in primary healthcare, follow-up of chronic patients, and health promotion in the community.

Complementing his medical training, Dr. João Silva also completed a Postgraduate Degree in Continuing and Palliative Care at CESPU, strengthening his preparation in the comprehensive approach to patient care, especially in situations requiring prolonged care and multidisciplinary support.

Camera Book a video appointment
€55

Frequently Asked Questions

Is a prescription required for RABEPRAZOL SANDOZ 20 mg GASTRO-RESISTANT TABLETS?
RABEPRAZOL SANDOZ 20 mg GASTRO-RESISTANT TABLETS requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in RABEPRAZOL SANDOZ 20 mg GASTRO-RESISTANT TABLETS?
The active ingredient in RABEPRAZOL SANDOZ 20 mg GASTRO-RESISTANT TABLETS is rabeprazole. This information helps identify medicines with the same composition but different brand names.
How much does RABEPRAZOL SANDOZ 20 mg GASTRO-RESISTANT TABLETS cost in pharmacies?
The average pharmacy price for RABEPRAZOL SANDOZ 20 mg GASTRO-RESISTANT TABLETS is around 24.37 EUR. Prices may vary depending on the manufacturer and dosage form.
Who manufactures RABEPRAZOL SANDOZ 20 mg GASTRO-RESISTANT TABLETS?
RABEPRAZOL SANDOZ 20 mg GASTRO-RESISTANT TABLETS is manufactured by Sandoz Farmaceutica S.A.. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of RABEPRAZOL SANDOZ 20 mg GASTRO-RESISTANT TABLETS online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether RABEPRAZOL SANDOZ 20 mg GASTRO-RESISTANT TABLETS is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to RABEPRAZOL SANDOZ 20 mg GASTRO-RESISTANT TABLETS?
Other medicines with the same active substance (rabeprazole) include PARIET 10 mg GASTRO-RESISTANT TABLETS, PARIET 20 mg GASTRO-RESISTANT TABLETS, RABEPRAZOL ALMUS 20 mg GASTRO-RESISTANT TABLETS. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media